Cartesian Therapeutics
The Director, Process Development leads the development, characterization, and commercialization of autologous cell therapy manufacturing processes. This role ensures processes are robust, scalable, and well-characterized to support regulatory submissions, process validation, and commercial manufacturing. The position provides technical leadership across process development, control strategy, and technology transfer while collaborating with cross-functional teams to advance programs from late-stage development through licensure.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cartesian Therapeutics.
21% above the average for this role